Usefulness of the simultaneous determination of serum levels of theophylline and its metabolites in patients medicated with theophylline preparation

被引:2
作者
Watanabe, Yuko [1 ,2 ]
Chohnabayashi, Naohiko [3 ]
Nasu, Hideki [3 ]
Nishimura, Naoki [3 ]
Uchiyama, Noboru [3 ]
Kizu, Junko [1 ]
机构
[1] Keio Univ, Dept Pract Pharm, Fac Pharm, Minato Ku, Tokyo 1058512, Japan
[2] Saiseikai Yokohamashi Nanbu Hosp, Dept Pharm, Kounan Ku, Yokohama, Kanagawa 2348503, Japan
[3] St Lukes Int Hosp, Dept Resp Med, Chuo Ku, Tokyo 1048560, Japan
关键词
theophylline; 1,3-dimethyluric acid; HPLC; LIQUID-CHROMATOGRAPHY;
D O I
10.1002/bmc.1473
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Objective: Measurement of the serum level of theophylline is essential for its proper use; however, it is difficult to infer the metabolic ability of individual patients by only the serum theophylline level and to decide the appropriate medication. In this study, we simultaneously measured serum theophylline and metabolite levels in patients treated with theophylline, and investigated their usefulness. Experimental: The subjects were asthma patients who visited the outpatient clinic of Respiratory Medicine, St Luke's International Hospital, between April and October 2003, and were medicated with sustained-release theophylline tablets (Theodur r). The serum level of theophylline and its metabolites was measured by HPLC in patients who gave written consent. Results: A strong correlation was noted between the serum theophylline (TP) and 1,3-dimethyluric acid (DMU) levels of 52 patients (r = 0.670), and DMU/TP was about 0.04. In a patient whose the DMU/TP was 0.216, it was recognized that metabolic ability was promoted due to a history of smoking. Discussion: In this study, it was shown that simultaneous measurement by HPLC of the serum level of theophylline and its metabolites and DMU/TP was useful to assess the metabolic ability of individual patients. Copyright (c) 2010 John Wiley & Sons, Ltd.
引用
收藏
页码:432 / 434
页数:3
相关论文
共 10 条
  • [1] JENNE JW, 1976, CLIN PHARMACOL THER, V19, P375
  • [2] Simultaneous determination of theophylline and its metabolites by HPLC
    Kanazawa, H
    Kizu, J
    Matsushima, Y
    [J]. YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2000, 120 (10): : 1051 - 1060
  • [3] Kizu J, 1999, BIOMED CHROMATOGR, V13, P15, DOI 10.1002/(SICI)1099-0801(199902)13:1<15::AID-BMC766>3.3.CO
  • [4] 2-4
  • [5] KIZU J, 2001, TDM KENKYU, V18, P248
  • [6] Kodera S, 1985, Arerugi, V34, P33
  • [7] EFFECTS OF PASSIVE SMOKING ON THEOPHYLLINE CLEARANCE
    MATSUNGA, SK
    PLEZIA, PM
    KAROL, MD
    KATZ, MD
    CAMILLI, AE
    BENOWITZ, NL
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 46 (04) : 399 - 407
  • [8] THOMPSON RD, 1974, J LAB CLIN MED, V84, P584
  • [9] TROGER U, 1995, CLIN PHARMACOKINET, V28, P287
  • [10] THEOPHYLLINE METABOLISM IN PREMATURE-INFANTS
    TSERNG, KY
    KING, KC
    TAKIEDDINE, FN
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 29 (05) : 594 - 600